Planning Alternatives Portfolio holdings
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.99M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.64M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.06M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.76M |
Top Sells
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$20.1M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$6.66M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.4M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$6.17M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.99M |
Sector Composition
| 1 | Technology | 1.6% |
| 2 | Consumer Staples | 0.4% |
| 3 | Industrials | 0.32% |
| 4 | Healthcare | 0.1% |
| 5 | Consumer Discretionary | 0.07% |
Similar funds
Planning Alternatives's Q4 2020 Portfolio in Review
As of Q4 2020, Planning Alternatives held 48 positions worth $564M, up 5.9% from $533M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Planning Alternatives withdrew a net $36M in Q4 2020, closing 5 positions and reducing 23 holdings. Its most notable exit was FlexShares Morningstar US Market Factors Tilt Index Fund, an estimated $577K position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, up from 1.5% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, Planning Alternatives opened a new position in Revance Therapeutics, Inc. worth $331K.
- Planning Alternatives's largest Q4 2020 buy was Revance Therapeutics, Inc.: 11,681 shares worth $331K.
- Planning Alternatives added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $3M increase.
- Planning Alternatives's biggest Q4 2020 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $20.1M.
- Planning Alternatives fully exited FlexShares Morningstar US Market Factors Tilt Index Fund in Q4 2020, selling an estimated $577K.
- Planning Alternatives's ten largest holdings make up 86% of its $564M portfolio in Q4 2020.
- Planning Alternatives opened 3 new positions and closed 5 in Q4 2020.
- Planning Alternatives's portfolio value rose 5.9% quarter-over-quarter to $564M.
Based on Planning Alternatives's 13F filing for Q4 2020, filed 29 Jan 2021.